Central Library

Demeter, Judit - Highly cited papers

Below listed the Semmelweis University affiliated publications of the author which are currently qualified as "Highly Cited" in Web of Science database

Number of publications: 3

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Mesa, RA;Vannucchi, AM;Mead, A;Egyed, M;Szoke, A;Suvorov, A;Jakucs, J;Perkins, A;Prasad, R;Mayer, J;Demeter, J;Ganly, P;Singer, JW;Zhou, HF;Dean, JP;te Boekhorst, PA;Nangalia, J;Kiladjian, JJ;Harrison, CN

LANCET HAEMATOLOGY

2017.

DOI:10.1016/S2352-3026(17)30027-3 (Copy DOI)

Semmelweis University authors: Demeter, Judit,

Semmelweis University departments: Semmelweis University, Faculty of Medicine,

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

Dreyling, M;Santoro, A;Mollica, L;Leppä, S;Follows, GA;Lenz, G;Kim, WS;Nagler, A;Panayiotidis, P;Demeter, J;Özcan, M;Kosinova, M;Bouabdallah, K;Morschhauser, F;Stevens, DA;Trevarthen, D;Giurescu, M;Cupit, L;Liu, L;Köchert, K;Seidel, H;Peña, C;Yin, SX;Hiemeyer, F;Garcia-Vargas, J;Childs, BH;Zinzani, PL

JOURNAL OF CLINICAL ONCOLOGY

2017.

DOI:10.1200/JCO.2017.75.4648 (Copy DOI)

Semmelweis University authors: Demeter, Judit,

Semmelweis University departments: Semmelweis University, Faculty of Medicine,

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

Vitolo, U;Trneny, M;Belada, D;Burke, JM;Carella, AM;Chua, N;Abrisqueta, P;Demeter, J;Flinn, I;Hong, X;Kim, WS;Pinto, A;Shi, YK;Tatsumi, Y;Oestergaard, MZ;Wenger, M;Fingerle-Rowson, G;Catalani, O;Nielsen, T;Martelli, M;Sehn, LH

JOURNAL OF CLINICAL ONCOLOGY

2017.

DOI:10.1200/JCO.2017.73.3402 (Copy DOI)

Semmelweis University authors: Demeter, Judit,

Semmelweis University departments: Semmelweis University, Faculty of Medicine,